Hubei Guangji Pharmaceutical Co Ltd (000952) — Free Cash Flow Generation Index
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥13.71 Million represents 1% of operating cash flow (CN¥22.38 Million). Explore Hubei Guangji Pharmaceutical Co Ltd (000952) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Hubei Guangji Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see how efficiently does Hubei Guangji Pharmaceutical Co Ltd generate cash.
Annual Free Cash Flow Generation for Hubei Guangji Pharmaceutical Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Hubei Guangji Pharmaceutical Co Ltd. Check how aggressively does Hubei Guangji Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | CN¥24.79 Million | CN¥60.43 Million | CN¥35.64 Million | ▲ +100.2% |
| 2024 | -235.41x | CN¥-154.28 Million | CN¥655.36K | CN¥154.93 Million | ▼ -6590.0% |
| 2022 | -3.52x | CN¥-158.63 Million | CN¥45.08 Million | CN¥203.71 Million | ▼ -1190.4% |
| 2021 | -0.27x | CN¥-20.70 Million | CN¥75.91 Million | CN¥96.61 Million | ▼ -251.5% |
| 2020 | 0.18x | CN¥21.49 Million | CN¥119.38 Million | CN¥97.89 Million | ▲ +6.2% |
| 2019 | 0.17x | CN¥24.44 Million | CN¥144.20 Million | CN¥119.76 Million | ▼ -74.7% |
| 2018 | 0.67x | CN¥154.91 Million | CN¥231.44 Million | CN¥76.53 Million | ▲ +22.2% |
| 2017 | 0.55x | CN¥97.92 Million | CN¥178.83 Million | CN¥80.91 Million | ▲ +69.0% |
| 2016 | 0.32x | CN¥54.13 Million | CN¥167.07 Million | CN¥112.94 Million | ▼ -31.7% |
| 2013 | 0.47x | CN¥45.12 Million | CN¥95.16 Million | CN¥50.04 Million | ▲ +642.6% |
| 2012 | -0.09x | CN¥-9.44 Million | CN¥108.02 Million | CN¥117.46 Million | ▲ +94.0% |
| 2011 | -1.45x | CN¥-119.08 Million | CN¥81.88 Million | CN¥200.96 Million | ▼ -192.4% |
| 2010 | -0.50x | CN¥-38.39 Million | CN¥77.18 Million | CN¥115.57 Million | ▼ -11809.9% |
| 2008 | 0.00x | CN¥937.45K | CN¥220.70 Million | CN¥219.76 Million | ▼ -99.5% |
| 2007 | 0.85x | CN¥283.03 Million | CN¥331.98 Million | CN¥48.94 Million | ▲ +0.1% |
| 2006 | 0.85x | CN¥107.23 Million | CN¥125.95 Million | CN¥18.73 Million | ▲ +62.9% |
| 2005 | 0.52x | CN¥28.30 Million | CN¥54.14 Million | CN¥25.84 Million | ▲ +55.1% |
| 2002 | 0.34x | CN¥25.68 Million | CN¥76.20 Million | CN¥50.52 Million | ▼ -30.2% |
| 2000 | 0.48x | CN¥23.46 Million | CN¥48.57 Million | CN¥25.11 Million | ▲ +149.4% |
| 1999 | -0.98x | CN¥-67.01 Million | CN¥68.57 Million | CN¥135.58 Million | — |